TW202023590A - 包含細菌菌株之組合物 - Google Patents

包含細菌菌株之組合物 Download PDF

Info

Publication number
TW202023590A
TW202023590A TW108129383A TW108129383A TW202023590A TW 202023590 A TW202023590 A TW 202023590A TW 108129383 A TW108129383 A TW 108129383A TW 108129383 A TW108129383 A TW 108129383A TW 202023590 A TW202023590 A TW 202023590A
Authority
TW
Taiwan
Prior art keywords
composition
present
bacterial
strain
mrx0004
Prior art date
Application number
TW108129383A
Other languages
English (en)
Chinese (zh)
Inventor
映姆科 伊莉莎白 慕得
馬斯里歐 亞德里安尼
艾咪 貝絲 赫特
瑪莉亞 克里斯托夫
菲力浦 科威
艾瑪 拉法蒂斯
卡利 達芬 路易斯 克勞黛 羅特
艾瑪 伊莉莎白 克萊爾 軒尼詩
蘇艾德 亞曼德
安娜 艾托爾
Original Assignee
英商4D製藥研究有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1817648.7A external-priority patent/GB201817648D0/en
Priority claimed from GBGB1900335.9A external-priority patent/GB201900335D0/en
Priority claimed from GBGB1901203.8A external-priority patent/GB201901203D0/en
Application filed by 英商4D製藥研究有限公司 filed Critical 英商4D製藥研究有限公司
Publication of TW202023590A publication Critical patent/TW202023590A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
TW108129383A 2018-08-17 2019-08-16 包含細菌菌株之組合物 TW202023590A (zh)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
EP18189521 2018-08-17
EP18189521.0 2018-08-17
GBGB1817648.7A GB201817648D0 (en) 2018-10-29 2018-10-29 Compositions comprising bacterial strains
GB1817648.7 2018-10-29
GBGB1900335.9A GB201900335D0 (en) 2019-01-10 2019-01-10 Compositions comprising bacterial strains
GB1900335.9 2019-01-10
GBGB1901203.8A GB201901203D0 (en) 2019-01-29 2019-01-29 Compositions comprising bacterial strains
GB1901203.8 2019-01-29

Publications (1)

Publication Number Publication Date
TW202023590A true TW202023590A (zh) 2020-07-01

Family

ID=67874412

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108129383A TW202023590A (zh) 2018-08-17 2019-08-16 包含細菌菌株之組合物

Country Status (14)

Country Link
US (1) US20210330786A1 (cg-RX-API-DMAC7.html)
EP (1) EP3836945A1 (cg-RX-API-DMAC7.html)
JP (1) JP2021534089A (cg-RX-API-DMAC7.html)
KR (1) KR20210046007A (cg-RX-API-DMAC7.html)
CN (1) CN113423413A (cg-RX-API-DMAC7.html)
AU (1) AU2019322090A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021002917A2 (cg-RX-API-DMAC7.html)
CA (1) CA3108235A1 (cg-RX-API-DMAC7.html)
IL (1) IL280895A (cg-RX-API-DMAC7.html)
MA (1) MA53228A (cg-RX-API-DMAC7.html)
MX (1) MX2021001888A (cg-RX-API-DMAC7.html)
SG (1) SG11202101580TA (cg-RX-API-DMAC7.html)
TW (1) TW202023590A (cg-RX-API-DMAC7.html)
WO (1) WO2020035623A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112195123B (zh) * 2020-10-12 2022-04-29 中科美大(福建)生物科技有限公司 一种植物乳杆菌及其制剂和应用
CN112522248B (zh) * 2020-11-10 2023-10-03 暨南大学 一种包裹型阴沟肠杆菌y16固体菌剂的制备方法及其应用
US20250002955A1 (en) * 2021-09-21 2025-01-02 Tohoku University Method for Promoting Production of Exopolysaccharide by Bifidobacterium Bacteria
CN119144528B (zh) * 2024-11-20 2025-06-06 青岛诺和诺康生物科技有限公司 两歧双歧杆菌及其改善哮喘及组胺不耐受的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127916D0 (en) 2001-11-21 2002-01-16 Rowett Res Inst Method
CA2667167C (en) 2006-10-27 2014-02-18 Pfizer Products Inc. Hydroxypropyl methyl cellulose hard capsules and process of manufacture
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
KR101156340B1 (ko) 2009-06-17 2012-06-13 고려대학교 산학협력단 비피도박테리움 브레베 lmc520 균주를 이용한 공액리놀렌산의 생산방법
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
WO2015156419A1 (en) * 2014-04-10 2015-10-15 Riken Compositions and methods for induction of th17 cells
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
LT3360559T (lt) * 2015-06-15 2019-12-27 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
CN116196340A (zh) 2016-05-31 2023-06-02 森永乳业株式会社 脑功能改善剂

Also Published As

Publication number Publication date
SG11202101580TA (en) 2021-03-30
JP2021534089A (ja) 2021-12-09
CN113423413A (zh) 2021-09-21
IL280895A (en) 2021-04-29
BR112021002917A2 (pt) 2021-05-11
US20210330786A1 (en) 2021-10-28
MX2021001888A (es) 2021-07-16
MA53228A (fr) 2021-11-24
CA3108235A1 (en) 2020-02-20
KR20210046007A (ko) 2021-04-27
EP3836945A1 (en) 2021-06-23
AU2019322090A1 (en) 2021-04-15
WO2020035623A1 (en) 2020-02-20

Similar Documents

Publication Publication Date Title
Papadimitriou et al. Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches
EP3377082B1 (en) Compositions comprising bacterial strains
TWI797067B (zh) 包含細菌菌株之組合物
EP3650033B1 (en) Compositions comprising bacterial strains
O'Flaherty et al. The role and potential of probiotic bacteria in the gut, and the communication between gut microflora and gut/host
US20210330786A1 (en) Compositions comprising bacterial strains
US11419931B2 (en) Compositions comprising bacterial strains
TW201907931A (zh) 包含細菌菌株之組合物
US20230048366A1 (en) Combination therapy for treating or preventing cancer
AU2024230804A1 (en) Compositions for modulating gut microflora populations, treatment of dysbiosis and disease prevention, and methods for making and using same
Zhang et al. Milk fat globule membrane protects Bifidobacterium longum ssp. infantis ATCC 15697 against bile stress by modifying global transcriptional responses
CN119072244A (zh) 用于治疗疾病的细菌菌株
OA20494A (en) Compositions comprising bacterial strains
US20210393773A1 (en) Compositions comprising bacterial strains
Buck Functional analysis of adhesion factors and signaling mechanisms in Lactobacillus acidophilus NCFM
Ceapa Phenotypic and genetic diversity of the species Lactobacillus rhamnosus
OA20782A (en) Compositions comprising bacterial strains.
HK40027894B (en) Compositions comprising bacterial strains
HK40027894A (en) Compositions comprising bacterial strains
HK1260158B (en) Compositions comprising bacterial strains